Dystonia and Dopaminergic Therapy: Rationale Derived from Pediatric Neurotransmitter Diseases
None
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2012
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/32231 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Dystonia and Dopaminergic Therapy: Rationale Derived from Pediatric Neurotransmitter Diseases
- Dopaminergic Control of the Neurotransmitter Release in the Subthalamic Nucleus: Implications for Parkinson’s Disease Treatment Strategies
- Dystonia, Spasticity and Botulinum Toxin Therapy: Rationale, Evidences and Clinical Context
- Dystonia Arising from Occupations: The Clinical Phenomenology and Therapy
- Dystonia and Muscle Spindles: The Link in Idiopathic Focal Dystonias
- Dystonia and Genetics
- Dopaminergic Differentiation Potential of Neural Precursor Cells Derived from Embryonic Stem Cells